Don S. Dizon, MD, FACP

Don S. Dizon, MD, FACP, is the director of the Oncology Sexual Health Clinic at Massachusetts General Hospital Cancer Center in Boston, Massachusetts.

Most Recent Articles by Don S. Dizon, MD, FACP

Engagement Is Survival: My Take on ASCO 2017

Engagement Is Survival: My Take on ASCO 2017

By

Don Dizon, MD: In addition to important clinical trial outcomes that evaluated novel strategies across tumor types, there were impressive studies aiming to help our patients live with cancer as well.

Case Study: Sexual Dysfunction Evaluation After Breast Cancer at an Oncology Sexual Health Clinic

Case Study: Sexual Dysfunction Evaluation After Breast Cancer at an Oncology Sexual Health Clinic

By

A case report that looks into a breast cancer survivor experiencing sex-related headaches after treatment.

Lost in Translation: Communicating with Newly Diagnosed Cancer Patients

Lost in Translation: Communicating with Newly Diagnosed Cancer Patients

By

Dr. Dizon and patient advocate Katherine O'Brien discuss the difficulty of communicating cancer and give advice on common miscommunications.

Expert Perspectives on Breast Cancer Awareness Month

Expert Perspectives on Breast Cancer Awareness Month

By

Editorial Board Member Don Dizon, MD, answers some questions about issues in breast cancer treatment today.

Reflections on Patient Perspectives and Survivorship from the 2013 Breast Cancer Symposium

Reflections on Patient Perspectives and Survivorship from the 2013 Breast Cancer Symposium

By

ChemotherapyAdvisor.com Editorial Board Member Don S. Dizon discusses survivorship issues from the 2013 Breast Cancer Symposium.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters